脳脊髄液管理の世界市場：洞察、競合情勢、市場予測：2030年

世界の脳脊髄液管理の市場規模は、2024年から2030年までの予測期間中に4.78%のCAGRで拡大すると予測されています。水頭症、脳腫瘍、頭蓋内圧亢進症などの神経疾患の有病率の上昇が、高度な脳脊髄液（CSF）管理システムの需要を大幅に押し上げています。さらに、外傷性脳損傷を頻繁に引き起こす外傷や事故の増加が市場をさらに牽引しています。これらの損傷では、患者の転帰をより確実にするために効果的な髄液管理が必要となるからです。さらに、主な市場開発企業による継続的な製品開発活動は、脳脊髄液管理の機能と特徴を強化し、患者の安全性を向上させる技術革新につながっており、2024年から2030年までの予測期間中の市場成長をさらに促進しています。

GLOBOCANが提供した最新データによると、2022年に世界で新たに発生した脳・中枢神経系がんの推定症例数は人口10万人当たり322,000人と推定され、2045年には人口10万人当たり474,000人に増加すると予測されています。

さらに、世界保健機関（WHO）の最新データ（2024年）によると、てんかんは全世界で約5,000万人が罹患しており、世界的に最も蔓延している神経疾患のひとつです。罹患者の80％近くが中低所得国に居住しています。

脳腫瘍などの神経疾患は、しばしば正常な脳脊髄液の流れや吸収を阻害し、水頭症や頭蓋内圧亢進などの症状を引き起こすため、脳脊髄液管理市場を大きく押し上げます。これらの疾患では、重篤な合併症を予防し、患者の転帰を最適なものにするために、正確で効果的な脳脊髄液管理が必要とされ、その結果、世界中の脳脊髄液管理市場全体が拡大しています。

当レポートでは、世界の脳脊髄液管理市場について調査し、市場の概要とともに、製品タイプ別、年齢層別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 脳脊髄液管理市場レポートのイントロダクション

第2章 脳脊髄液管理市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 脳脊髄液管理市場の主な要因分析

• 脳脊髄液管理の市場促進要因
• 脳脊髄液管理の市場抑制要因と課題
• 脳脊髄液管理の市場機会

第6章 脳脊髄液管理市場におけるポーターのファイブフォース分析

第7章 脳脊髄液管理市場の評価

• 製品タイプ別
• 年齢層別
• エンドユーザー別
• 地域別

第8章 脳脊髄液管理市場の企業と製品プロファイル

• Medtronic PLC
• B. Braun Melsungen AG
• Neuromedex GmbH
• Natus Medical Incorporated.
• Sophysa
• Integra LifeSciences Corporation
• Spiegelberg GmbH & Co. KG
• Desu Medical
• Polyganics
• CHRISTOPH MIETHKE GMBH & CO. KG
• HpBio Proteses Inc.
• Wellong Instruments Co., Ltd.
• Moller Medical GmbH
• CereVasc, Inc.
• Anuncia Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Cerebrospinal Fluid Management Market in Global (2021-2030)
• Table 3: Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)
• Table 4: Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)
• Table 5: Cerebrospinal Fluid Management Market in Global by End-User (2021-2030)
• Table 6: Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)
• Table 7: Cerebrospinal Fluid Management Market in North America (2021-2030)
• Table 8: Cerebrospinal Fluid Management Market in the United States (2021-2030)
• Table 9: Cerebrospinal Fluid Management Market in Canada (2021-2030)
• Table 10: Cerebrospinal Fluid Management Market in Mexico (2021-2030)
• Table 11: Cerebrospinal Fluid Management Market in Europe (2021-2030)
• Table 12: Cerebrospinal Fluid Management Market in France (2021-2030)
• Table 13: Cerebrospinal Fluid Management Market in Germany (2021-2030)
• Table 14: Cerebrospinal Fluid Management Market in United Kingdom (2021-2030)
• Table 15: Cerebrospinal Fluid Management Market in Italy (2021-2030)
• Table 16: Cerebrospinal Fluid Management Market in Spain (2021-2030)
• Table 17: Cerebrospinal Fluid Management Market in the Rest of Europe (2021-2030)
• Table 18: Cerebrospinal Fluid Management Market in Asia-Pacific (2021-2030)
• Table 19: Cerebrospinal Fluid Management Market in China (2021-2030)
• Table 20: Cerebrospinal Fluid Management Market in Japan (2021-2030)
• Table 21: Cerebrospinal Fluid Management Market in India (2021-2030)
• Table 22: Cerebrospinal Fluid Management Market in Australia (2021-2030)
• Table 23: Cerebrospinal Fluid Management Market in South Korea (2021-2030)
• Table 24: Cerebrospinal Fluid Management Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Cerebrospinal Fluid Management Market in the Rest of the World (2021-2030)
• Table 26: Cerebrospinal Fluid Management Market in the Middle East (2021-2030)
• Table 27: Cerebrospinal Fluid Management Market in Africa (2021-2030)
• Table 28: Cerebrospinal Fluid Management Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Cerebrospinal Fluid Management Market in Global (2021-2030)
• Figure 3: Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)
• Figure 4: Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)
• Figure 5: Cerebrospinal Fluid Management Market in Global by End-User (2021-2030)
• Figure 6: Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)
• Figure 7: Cerebrospinal Fluid Management Market in North America (2021-2030)
• Figure 8: Cerebrospinal Fluid Management Market in the United States (2021-2030)
• Figure 9: Cerebrospinal Fluid Management Market in Canada (2021-2030)
• Figure 10: Cerebrospinal Fluid Management Market in Mexico (2021-2030)
• Figure 11: Cerebrospinal Fluid Management Market in Europe (2021-2030)
• Figure 12: Cerebrospinal Fluid Management Market in France (2021-2030)
• Figure 13: Cerebrospinal Fluid Management Market in Germany (2021-2030)
• Figure 14: Cerebrospinal Fluid Management Market in United Kingdom (2021-2030)
• Figure 15: Cerebrospinal Fluid Management Market in Italy (2021-2030)
• Figure 16: Cerebrospinal Fluid Management Market in Spain (2021-2030)
• Figure 17: Cerebrospinal Fluid Management Market in the Rest of Europe (2021-2030)
• Figure 18: Cerebrospinal Fluid Management Market in Asia-Pacific (2021-2030)
• Figure 19: Cerebrospinal Fluid Management Market in China (2021-2030)
• Figure 20: Cerebrospinal Fluid Management Market in Japan (2021-2030)
• Figure 21: Cerebrospinal Fluid Management Market in India (2021-2030)
• Figure 22: Cerebrospinal Fluid Management Market in Australia (2021-2030)
• Figure 23: Cerebrospinal Fluid Management Market in South Korea (2021-2030)
• Figure 24: Cerebrospinal Fluid Management Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Cerebrospinal Fluid Management Market in the Rest of the World (2021-2030)
• Figure 26: Cerebrospinal Fluid Management Market in the Middle East (2021-2030)
• Figure 27: Cerebrospinal Fluid Management Market in Africa (2021-2030)
• Figure 28: Cerebrospinal Fluid Management Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Market Opportunities
• Figure 32: PORTER'S Five Force Analysis

Cerebrospinal Fluid Management Market by Product Type (CSF Shunts & Valves, External Drainage Systems [Drainage & Monitoring Systems, Drainage-Specific Systems, and CSF Drainage Catheters {Ventricular, Lumbar, and Others}], Anti-Siphon Devices, and Others), Age Group (Adult and Pediatric), End User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of neurological conditions, increasing number of trauma & accidents, and increase in product development activities by key market players across the globe.

The global cerebrospinal fluid management market was valued at USD XX billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2024 to 2030 to reach XX billion by 2030. The growing prevalence of neurological conditions like hydrocephalus, brain tumors, and intracranial hypertension is significantly boosting the demand for advanced cerebrospinal fluid (CSF) management systems. Additionally, the rise in trauma and accidents, which frequently result in traumatic brain injuries, is further driving the market, as these injuries require effective CSF management to ensure better patient outcomes. Furthermore, the ongoing product development activities by key market players are enhancing the capabilities and features of cerebrospinal fluid management, leading to innovations that improve patient safety further propelling the market growth during forecast period from 2024 to 2030.

Cerebrospinal Fluid Management Market Dynamics:

According to the recent data provided by the GLOBOCAN, in 2022, globally the estimated new cases of brain and central nervous system cancer was estimated to be 322,000 per 100,000 population and the projection were estimated to increase 474,000 per 100,000 population by 2045.

Additionally, as per the recent data provided by the World Health Organization (2024), epilepsy affects approximately 50 million people worldwide, making it one of the most prevalent neurological disorders globally. Nearly 80% of those affected reside in low- and middle-income countries.

Neurological disorders such as brain tumors significantly boost the market for cerebrospinal fluid management because they often lead to the disruption of normal cerebrospinal fluid flow or absorption, resulting in conditions like hydrocephalus or increased intracranial pressure. These disorders necessitate precise and effective management of cerebrospinal fluid to prevent severe complications and ensure optimal patient outcomes thereby escalating the overall market of cerebrospinal fluid management across the globe.

Additionally, as per the data provided by the World Health Organization (WHO) 2023, approximately 20 to 50 million people suffer from non-fatal road traffic accidents worldwide, every year. As road traffic accidents continue to be a leading cause of traumatic brain injuries worldwide, the demand for advanced cerebrospinal fluid management systems is expected to rise as when a severe head injury occurs, it can disrupt the normal flow and absorption of cerebrospinal fluid, leading to increased intracranial pressure and the risk of further complications hence, thereby escalating the overall market of cerebrospinal fluid management across the globe.

Along with the factors mentioned above, the increase in product development activities are also expected to aid in the growth of the cerebrospinal fluid management market. For instance, in March 2021, Anuncia Inc. received the ""Breakthrough Device Designation"" for ReFlow(TM) System Mini by the US FDA. The device is to be used in the treatment of CSF disorders requiring shunting such as hydrocephalus.

However, the stringent regulatory product approval process, common risks associated with the devices such as infection, shunt malfunction, and improper drainage, among others may hinder the growth of cerebrospinal fluid management.

Cerebrospinal Fluid Management Market Segment Analysis:

Cerebrospinal Fluid Management Market by Product Type (CSF Shunts & Valves, External Drainage Systems [Drainage & Monitoring Systems, Drainage-Specific Systems, and CSF Drainage Catheters {Ventricular, Lumbar, and Others}], Anti-Siphon Devices, and Others), Age Group (Adult and Pediatric), End User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall cerebrospinal fluid management market, the CSF shunts & valves are expected to hold the largest share in the year 2023. CSF shunts and valves play a crucial role in boosting the overall market for cerebrospinal fluid (CSF) management systems by addressing the essential need for effective regulation of CSF flow in patients with conditions like hydrocephalus and intracranial hypertension. These devices are designed to divert excess cerebrospinal fluid from the brain's ventricles to other parts of the body, such as the abdominal cavity, where it can be safely absorbed. Their ability to provide targeted, long-term solutions for managing abnormal CSF accumulation has made them indispensable in clinical practice. Innovations in shunt and valve technology, such as improvements in biocompatibility, miniaturization, and programmable features, have enhanced their effectiveness and patient outcomes. This has led to increased adoption and demand for advanced CSF management systems across hospitals and clinics. As a result, the market for CSF management systems has experienced significant growth, driven by the need for more precise, reliable, and minimally invasive solutions to manage complex neurological conditions.

Additionally, the ongoing strategic activities across the globe further spurs the market of CSF shunts & valves. For instance, in May 2024, CereVasc received the FDA IDE approval for the STRIDE Pivotal study of the eShunt System for treatment of normal pressure hydrocephalus.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global cerebrospinal fluid management market during the forecast period.

North America is expected to dominate the overall cerebrospinal fluid management market:

Among all the regions, North America is expected to hold the largest share in the global cerebrospinal fluid management market in 2023. The growing prevalence of traumatic brain injuries, neurological disorders such as epilepsy, Alzheimer's, and Parkinson's disease across the region is escalating the overall market of cerebrospinal fluid management across the region. Additionally, recent product developmental activities, and rising government initiatives are expected to aid in the growth of the North American cerebrospinal fluid management market during the forecast period from 2024 to 2030.

As per the recent data provided by Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the United States. Additionally, as per the recent data provided by the Alzheimer's Association, in 2024, approximately 6.9 million Americans age 65 and older are living with Alzheimer's. Thus, these neurodegenerative conditions result in the progressive deterioration of brain cells, which can lead to disruptions in the normal production, circulation, or absorption of cerebrospinal fluid. Patients with advanced Parkinson's and Alzheimer's are more prone to develop hydrocephalus-a condition marked by the accumulation of cerebrospinal fluid in the brain's ventricles. This condition often requires the implantation of cerebrospinal fluid shunts or external drainage systems for management thereby escalating the overall market of cerebrospinal fluid management across the region.

Moreover, as per the recent data provided by the Centers for Disease Control and Prevention (2024) each year in United States, about 1,427 babies were born with spina bifida, or 1 in every 2,758 births in the country. Many babies born with spina bifida also develop hydrocephalus which may boost the demand for CSF management devices such as hydrocephalus shunts, eventually driving the CSF management market across the region growth during the forecast period.

Additionally, according to the recent data provided by the Brain Aneurysm Foundation (2024), an estimated 6.5 million people in the United States had an un-ruptured brain aneurysm. The annual rate of rupture in the country was approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffered a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. It had been established that blood from a torn aneurysm can result in the blockage of CSF circulation leading to fluid buildup and increased pressure on the brain ultimately causing hydrocephalus. Therefore, the increase in number of patients suffering from brain aneurysms in the country is expected to drive the demand for CSF management devices, thereby contributing in the overall growth of the CSF management market in the North American region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for cerebrospinal fluid management. For instance, in July 2023, Anuncia Medical successfully launched second generation device, ReFlow(TM) Mini Flusher device, to treat hydrocephalus at several leading neurosurgical centers across the United States.

Therefore, the interplay of above mentioned various factors in the region are expected to boost the North America cerebrospinal fluid management market during the forecast period.

Cerebrospinal Fluid Management Market Key Players:

Some of the key market players operating in the cerebrospinal fluid management market include Medtronic PLC, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc., Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc., and others.

Recent Developmental Activities in the Cerebrospinal Fluid Management Market:

• In May 2024, FDA approved CereVasc's eShunt system study for hydrocephalus.
• In November 2023, Pramand launched CraniSeal(TM) Dural Sealant, an absorbable polyethylene glycol (PEG) hydrogel that is applied with an applicator over sutures. This sealant prevents cerebrospinal fluid from leaking out of a cranial surgery incision site.
• In June 2023, Roche received FDA clearance for additional Alzheimer's disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making.

Key Takeaways From the Cerebrospinal Fluid Management Market Report Study:

• Market size analysis for current cerebrospinal fluid management size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the cerebrospinal fluid management market.
• Various opportunities available for the other competitors in the cerebrospinal fluid management market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current cerebrospinal fluid management market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for cerebrospinal fluid management market growth in the coming future?

Target Audience who can be Benefited From This Cerebrospinal Fluid Management Market Report Study:

• Cerebrospinal fluid management product providers
• Research organizations and consulting companies
• Cerebrospinal fluid management -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in cerebrospinal fluid management
• Various end-users who want to know more about the cerebrospinal fluid management market and the latest technological developments in the cerebrospinal fluid management market.

Frequently Asked Questions for the Cerebrospinal Fluid Management Market:

1. What are cerebrospinal fluid management?

• Cerebrospinal fluid management devices are used in the treatment of CSF accumulation and leakage in events of hydrocephalus and injuries due to various reasons such as birth defects, trauma, and other causes. These include devices such as CSF shunts, dual sealants, and intracranial pressure monitoring devices among others.

2. What is the market for cerebrospinal fluid management?

• The global cerebrospinal fluid management market was valued at USD XX billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2024 to 2030 to reach XX billion by 2030.

3. What are the drivers for the cerebrospinal fluid management market?

• The growing prevalence of neurological conditions like hydrocephalus, brain tumours, and intracranial hypertension is significantly boosting the demand for advanced cerebrospinal fluid (CSF) management systems. Additionally, the rise in trauma and accidents, which frequently result in traumatic brain injuries, is further driving the market, as these injuries require effective CSF management to ensure better patient outcomes. Furthermore, the ongoing product development activities by key market players are enhancing the capabilities and features of cerebrospinal fluid management, leading to innovations that improve patient safety further propelling the market growth during forecast period from 2024 to 2030.

4. Who are the key players operating in the cerebrospinal fluid management market?

• Some of the key market players operating in the cerebrospinal fluid management market include Medtronic PLC, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc., Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc., and others.

5. Which region has the highest share in the cerebrospinal fluid management market?

• Among all the regions, North America is expected to hold the largest share in the global cerebrospinal fluid management market in 2023. The growing prevalence of traumatic brain injuries, neurological disorders such as epilepsy, Alzheimer's, and Parkinson's disease across the region is escalating the overall market of cerebrospinal fluid management across the region. Additionally, recent product developmental activities, and rising government initiatives are expected to aid in the growth of the North American cerebrospinal fluid management market during the forecast period from 2024 to 2030.

Table of Contents

1. Cerebrospinal Fluid Management Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Cerebrospinal Fluid Management Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Cerebrospinal Fluid Management Market Key Factors Analysis

• 5.1. Cerebrospinal Fluid Management Market Drivers
  • 5.1.1. Growing incidence of neurological disorders
  • 5.1.2. Increasing cases of trauma and accidents
  • 5.1.3. Increase in product development activities by key market players across the globe
• 5.2. Cerebrospinal Fluid Management Market Restraints and Challenges
  • 5.2.1. Risk associated with cerebrospinal fluid management such as bleeding, infection, shunt malfunction, and others
  • 5.2.2. Stringent regulatory concerns for product approval
• 5.3. Cerebrospinal Fluid Management Market Opportunities
  • 5.3.1. Innovation such as smart shunts with integrated sensors for real-time monitoring and automated drainage systems

6. Cerebrospinal Fluid Management Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Cerebrospinal Fluid Management Market Assessment

• 7.1. By Product Type
  • 7.1.1. CSF Shunts and Valves
  • 7.1.2. External Drainage Systems
    • 7.1.2.1. Drainage and Monitoring Systems
    • 7.1.2.2. Drainage-Specific Systems
    • 7.1.2.3. CSF Drainage Catheters
    • 7.1.2.3.1. Ventricular
    • 7.1.2.3.2. Lumbar
    • 7.1.2.3.3. Other
  • 7.1.3. Anti-Siphon Devices
  • 7.1.4. Others
• 7.2. By Age Group
  • 7.2.1. Adults
  • 7.2.2. Pediatric
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.1.2. Canada Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.1.3. Mexico Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.2.2. Germany Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.2.3. United Kingdom Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.2.4. Italy Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.2.5. Spain Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.2.6. Rest of Europe Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.3.2. Japan Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.3.3. India Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.3.4. Australia Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.3.5. South Korea Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.4.2. Africa Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)
    • 7.4.4.3. South America Cerebrospinal Fluid Management Market Size in USD Million (2021-2030)

8. Cerebrospinal Fluid Management Market Company and Product Profiles

• 8.1. Medtronic PLC
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. B. Braun Melsungen AG
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Neuromedex GmbH
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Natus Medical Incorporated.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Sophysa
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Integra LifeSciences Corporation
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Spiegelberg GmbH & Co. KG
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Desu Medical
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Polyganics
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. CHRISTOPH MIETHKE GMBH & CO. KG
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. HpBio Proteses Inc.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Wellong Instruments Co., Ltd.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Moller Medical GmbH
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. CereVasc, Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Anuncia Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us